August 9, 2021
Shardul Amarchand Mangaldas & Co. advised LeapFrog Investments (“LeapFrog”) in $31.1 million Series C round of investment in Medgenome Inc., which was led by International Finance Corporation.
The transaction team was led by Anuj Bhasme, Partner; Avichal Mathur, Principal Associate; Hardik Thakker, Senior Associate; and Shreeya Shukla, Associate.
Debevoise & Plimpton LLP advised LeapFrog on US aspects. Algo Legal advised Medgenome Inc.
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that:
Click here for important public notice from the Firm.